Agilent
Operates in the area of life sciences, diagnostics and applied chemical markets; a spinout from Hewlett Packard.
Launch date
Employees
Market cap
€35.9b
Enterprise valuation
€36.9b (Public information from Sep 2024)
Share price
$137.31 A
Santa Clara California (HQ & founding location)
Corporate Venture Fund: Agilent Ventures
Financials
Estimates*
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 5.3b | 6.3b | 6.8b | 6.8b | 6.5b | 6.8b | 7.3b |
| % growth | 3 % | 18 % | 8 % | - | (5 %) | 5 % | 7 % |
| EBITDA | 1.2b | 1.8b | 1.9b | 1.7b | 1.9b | 2.1b | 2.3b |
| % EBITDA margin | 23 % | 28 % | 28 % | 25 % | 29 % | 30 % | 31 % |
| Profit | 719m | 1.2b | 1.3b | 1.2b | 1.3b | 1.4b | 1.5b |
| % profit margin | 13 % | 19 % | 18 % | 18 % | 20 % | 20 % | 20 % |
| EV / revenue | 6.1x | 7.7x | 6.2x | 4.6x | 6.6x | 6.2x | 5.8x |
| EV / EBITDA | 26.4x | 27.7x | 22.4x | 18.4x | 22.6x | 20.3x | 18.9x |
| R&D budget | 495m | 441m | 467m | 481m | - | - | - |
| R&D % of revenue | 9 % | 7 % | 7 % | 7 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | Corporate spinout | |
* | N/A | $2.1b | IPO |
| N/A | £750k | Seed | |
€190k | Grant | ||
* | N/A | $500m | Post IPO Debt |
| Total Funding | €1.1m | ||
Related Content
Recent News about Agilent
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
By Country
By Industry
Investments by Agilent
Edit
ACQUISITION by Ginkgo Bioworks Jan 2017
ACQUISITION by Agilent Mar 2011
ACQUISITION by Agilent Dec 2016
ACQUISITION by Agilent Sep 2015
ACQUISITION by Agilent Jul 2009
ACQUISITION by Agilent Jun 2008
ACQUISITION by Agilent Apr 2018
ACQUISITION by Agilent Jun 2012
ACQUISITION by BioNano Genomics Nov 2022
ACQUISITION by Agilent Jul 2024